Literature DB >> 6339403

Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

L Hagberg, I Engberg, R Freter, J Lam, S Olling, C Svanborg Edén.   

Abstract

A model for ascending unobstructed urinary tract infection was developed in mice to study the pathogenesis of urinary tract infection induced by Escherichia coli associated with urinary tract infection in humans. Specifically, the model was designed to monitor the initial stages of the infectious process, e.g., bacterial adhesion. Mice were selected since the specificity and intensity of bacterial attachment of pyelonephritogenic E. coli strains to human and mouse uroepithelial cells were similar. Female mice were infected by urethral catheterization and installation of bacteria in the urinary bladder. To maximize clearance of unattached bacteria, no obstructive manipulations were performed. After sacrifice, the persistence of bacteria in kidneys and bladder was determined by viable counts on homogenized tissues. The experimental infection was standardized by using one pyelonephritis (HU734) and one normal fecal (414) E. coli isolate. With both strains all of the bladders became infected, but E. coli 414 was eliminated more rapidly than HU734. The percentage of positive kidney cultures increased with the bacterial inoculum concentration and volume. An inoculum of 0.05 ml containing 10(10) bacteria per ml was selected, giving the highest percentage of positive kidney cultures without detectable bacterial spread to the blood stream. The variation in the percentage of positive kidney cultures possibly depended on the degree of vesicoureteric reflux in the individual animals. Both in the kidneys and in the urinary bladders, strain HU734 yielded higher numbers of bacteria at 24 h and persisted longer than did strain 414. Several E. coli pyelonephritis isolates with properties associated with virulence in the human urinary tract consistently were recovered from mouse kidneys and bladders in higher numbers than E. coli strains of human fecal origin lacking those properties. The role of bacterial adhesion per se is the topic of the accompanying paper.

Entities:  

Mesh:

Year:  1983        PMID: 6339403      PMCID: PMC264845          DOI: 10.1128/iai.40.1.273-283.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Effect of polymyxin on the ultrastructure of the outer membrane of wild-type and polymyxin-resistant strain of Salmonella.

Authors:  K Lounatmaa; P H Mäkelä; M Sarvas
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

2.  Modified thiocarbohydrazide procedure for scanning electron microscopy: routine use for normal, pathological, or experimental tissues.

Authors:  L E Malick; R B Wilson
Journal:  Stain Technol       Date:  1975-07

3.  Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea.

Authors:  H W Smith; M A Linggood
Journal:  J Med Microbiol       Date:  1971-11       Impact factor: 2.472

4.  Experimental urinary tract infection with Pseudomonas aeruginosa in mice.

Authors:  T Nishi; K Tsuchiya
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

Review 5.  Adhesion of Escherichia coli in urinary tract infection.

Authors:  C S Edén; L Hagberg; L A Hanson; T Korhonen; H Leffler; S Olling
Journal:  Ciba Found Symp       Date:  1981

6.  Effect of immunization of bacterial adherence to urothelium.

Authors:  D T Uehling; K Mizutani; E Balish
Journal:  Invest Urol       Date:  1978-09

7.  Occurrence of P-fimbriated Escherichia coli in urinary tract infections.

Authors:  G Källenius; R Möllby; S B Svenson; I Helin; H Hultberg; B Cedergren; J Winberg
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

8.  Contribution of adhesion to bacterial persistence in the mouse urinary tract.

Authors:  L Hagberg; R Hull; S Hull; S Falkow; R Freter; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

9.  An experimental model for ascending acute pyelonephritis caused by Escherichia coli or proteus in rats.

Authors:  P Larsson; B Kaijser; I M Baltzer; S Olling
Journal:  J Clin Pathol       Date:  1980-04       Impact factor: 3.411

10.  Experimental pyelonephritis. XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis.

Authors:  W F Keane; L R Freedman
Journal:  Yale J Biol Med       Date:  1967-12
View more
  175 in total

1.  Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.

Authors:  Sébastien Crépin; Sébastien Houle; Marie-Ève Charbonneau; Michaël Mourez; Josée Harel; Charles M Dozois
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Proteobactin and a yersiniabactin-related siderophore mediate iron acquisition in Proteus mirabilis.

Authors:  Stephanie D Himpsl; Melanie M Pearson; Carl J Arewång; Tyler D Nusca; David H Sherman; Harry L T Mobley
Journal:  Mol Microbiol       Date:  2010-10       Impact factor: 3.501

3.  An Escherichia coli reference collection group B2- and uropathogen-associated polymorphism in the rpoS-mutS region of the E. coli chromosome.

Authors:  D E Culham; J M Wood
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

4.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 5.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

6.  Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity.

Authors:  Chelsie E Armbruster; Sara N Smith; Alejandra Yep; Harry L T Mobley
Journal:  J Infect Dis       Date:  2013-11-26       Impact factor: 5.226

7.  Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.

Authors:  Xin Li; C Virginia Lockatell; David E Johnson; M Chelsea Lane; John W Warren; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice.

Authors:  L Hagberg; R Hull; S Hull; J R McGhee; S M Michalek; C Svanborg Edén
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

9.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

10.  Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder.

Authors:  Tamako A Garcia; Christy L Ventura; Mark A Smith; D Scott Merrell; Alison D O'Brien
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.